Skip to content

Cancer Rose

News
Actions
Informations
Media library

Search for:

Cancer Rose

News
Actions
Informations
Media library

Cancer Rose

News
Actions
Informations
Media library

Search for:

Cancer Rose

News
Actions
Informations
Media library

Archives

Our latest 100 posts

08 Jun 2024

Mammography screening : truths, lies, controversy

08 Jun 2024

08 Jun 2024

08 Jun 2024

08 Jun 2024

Should i be tested for cancer ?

08 Jun 2024

08 Jun 2024

Conspiracy of hope

08 Jun 2024

08 Jun 2024

The history and mystery of breast cancer

08 Jun 2024

07 Jun 2024

CANTASKFORCE TOOL

07 Jun 2024

05 Jun 2024

Information leaflet

05 Jun 2024

31 May 2024

31 May 2024

30 May 2024

Screening mammography, yes or no ?

30 May 2024

30 May 2024

Mammography screening, what it’s like ?

30 May 2024

30 May 2024

Meet Cancer Rose

30 May 2024

30 May 2024

Cancer Rose Interactive decision support tool

30 May 2024

30 May 2024

Mechanisms of breast cancer

30 May 2024

17 Apr 2024

Digital Mammography

17 Apr 2024

13 Apr 2024

Too much, too mild, too early: the excessive expansion of diagnoses

13 Apr 2024

11 Apr 2024

Early diagnosis and a linear view of time: a dangerous link

11 Apr 2024

14 Feb 2024

Breast atypia, a lighter follow-up

14 Feb 2024

14 Feb 2024

Reflections of a radiologist

14 Feb 2024

18 Jan 2024

Reduced mortality attributable to screening? We talk about it again

18 Jan 2024

26 Oct 2023

Interview with researcher K.J.Jorgensen

26 Oct 2023

22 Oct 2023

Mammogram: YES or NO?

22 Oct 2023

30 Sep 2023

An interactive decision-support tool, for you!

30 Sep 2023

17 Sep 2023

Lowering the age of screening? A Pandora’s Box

17 Sep 2023

08 Sep 2023

Screenings don’t extend lifespan

08 Sep 2023

14 Jun 2023

The risk of death from breast cancer is declining, with screening or not

14 Jun 2023

16 May 2023

Lowering the age for starting screening, but at what cost?

16 May 2023

07 May 2023

Screening for…cytoliosis!

07 May 2023

01 Apr 2023

Overdiagnosis is underestimated in screenings, a systematic review

01 Apr 2023

20 Mar 2023

Breast density notifications: implications and overuse

20 Mar 2023

20 Feb 2023

Interval cancers, incidentalomas, the losers of screening

20 Feb 2023

28 Jan 2023

Stage 0 DCIS Saga

28 Jan 2023

29 Dec 2022

A letter from Ameli (French Health Insurance)

29 Dec 2022

14 Dec 2022

Screening: it is urgent to improve the information for women

14 Dec 2022

13 Dec 2022

13 Dec 2022

12 Dec 2022

12 Dec 2022

11 Dec 2022

Caution of the Council of European Union regarding screenings extension

11 Dec 2022

27 Oct 2022

Increase of cancers, an epidemic?

27 Oct 2022

20 Oct 2022

The short news of October 2022

20 Oct 2022

15 Oct 2022

The new INCa 2022 booklet on breast cancer screening

15 Oct 2022

25 Sep 2022

The irreversibility of screening

25 Sep 2022

22 Sep 2022

A new EU approach to cancer screening

22 Sep 2022

15 Sep 2022

Liquid biopsies, the Grail?

15 Sep 2022

12 Sep 2022

The risks of screening: an elephant in the room

12 Sep 2022

08 Sep 2022

Cancer screening for older adults; a bad idea

08 Sep 2022

01 Jul 2022

The effect of breast cancer screening is declining

01 Jul 2022

21 Jun 2022

21 Jun 2022

16 Jun 2022

Awareness of breast cancer overdiagnosis among women with breast cancer

16 Jun 2022

30 May 2022

Why don’t we change our vocabulary?

30 May 2022

28 May 2022

Potential benefits, as well as harms, from the COVID-19 disruption on cancer screening

28 May 2022

24 May 2022

Overdiagnosis, the silent pandemic of the West?

24 May 2022

23 May 2022

Preventing Overdiagnosis Conference-2022

23 May 2022

17 May 2022

Update on Tomosynthesis

17 May 2022

11 May 2022

Evaluation of information on screening, the situation in Italy, French parallel, and hope…

11 May 2022

30 Apr 2022

When marketing, finance, lobbying, and advertising invite themselves into the health care sector

30 Apr 2022

13 Apr 2022

Screening for cancer: the Good, the Bad and the Ugly

13 Apr 2022

13 Apr 2022

Cancer Screening—The Good, the Bad, and the Ugly

13 Apr 2022

28 Mar 2022

False-positive results in screening: tomosynthesis not effective enough

28 Mar 2022

27 Mar 2022

Respect patient preferences

27 Mar 2022

12 Mar 2022

A Modeling Study on Overdiagnosis

12 Mar 2022

18 Dec 2021

Anatomopathology, possible uncertainties

18 Dec 2021

18 Dec 2021

Explanation of the Cancer Rose Decision Support Tool

18 Dec 2021

15 Dec 2021

Detailed information for women

15 Dec 2021

05 Dec 2021

Decision-aid Cochrane / Baum

05 Dec 2021

27 Nov 2021

Dual-energy angiomammography

27 Nov 2021

15 Nov 2021

October, the cruelest month?

15 Nov 2021

05 Nov 2021

Screening can only detect slow cancers

05 Nov 2021

05 Nov 2021

Increasing the importance of early clinical diagnosis

05 Nov 2021

05 Nov 2021

Why does INCa instrumentalize women’s fear of having breast cancer and dying from it?

05 Nov 2021

02 Nov 2021

Bad statistic of the month October

02 Nov 2021

02 Nov 2021

BOOK “IM-PATIENTE”

02 Nov 2021

23 Oct 2021

How does a cancer develop ?

23 Oct 2021

23 Oct 2021

What is overdiagnosis ?

23 Oct 2021

19 Oct 2021

INCa still outrageously dishonest and unethical

19 Oct 2021

19 Oct 2021

What is the difference between a false alarm and cancer overdiagnosis?

19 Oct 2021

18 Oct 2021

What is “survival”?

18 Oct 2021

02 Oct 2021

Mrs. PL, 22 years of shared life with breast cancer, or the fight from a fierce “NO” to a half-hearted “YES.”

02 Oct 2021

02 Oct 2021

Health screening needs independent regular re-evaluation

02 Oct 2021

02 Sep 2021

Screening campaigns: a move toward greater caution?

02 Sep 2021

30 Aug 2021

Mammo or not mammo?

30 Aug 2021

26 Aug 2021

Mammo or Not Mammo ? A book for women (in French)

26 Aug 2021

25 Jul 2021

From cancer culture to cancel culture. Chronicle of a drift

25 Jul 2021

21 Jul 2021

Dream of a senologist

21 Jul 2021

13 Jul 2021

The National Institute of Cancer in France (Inca) relegates the question of the benefit-risk of organized breast cancer screening to the “Fake-news” rubric

13 Jul 2021

11 Jul 2021

Cover up that controversy, which one can’t endure to see

11 Jul 2021

05 Jul 2021

The cat knew it

05 Jul 2021

28 Jun 2021

Other information tools

28 Jun 2021

24 Jun 2021

Press Release – Cancer Rose

24 Jun 2021

22 Jun 2021

Cancer-rose – Press release June 2021

22 Jun 2021

22 Jun 2021

INCA : from bad surprises to bad surprises

22 Jun 2021

20 Jun 2021

Interview TV of Renée Pellerin

20 Jun 2021

12 Jun 2021

Conspiracy of Hope-a book of Renee Pellerin

12 Jun 2021

08 Jun 2021

French consultation is discussed in JAMA

08 Jun 2021

06 Jun 2021

Sophie’s testimonial

06 Jun 2021

05 Jun 2021

A Guide to Health and Medicine from the GIJN

05 Jun 2021

03 Jun 2021

Inequalities of screening during Covid-19, interview with V.Prasad

03 Jun 2021

01 Jun 2021

Radiation-induced cancers after radiotherapy for breast cancer

01 Jun 2021

23 May 2021

Informed consent/Letter CMAJ

23 May 2021

22 May 2021

Quaternary prevention

22 May 2021

01 May 2021

Interview with B. Duperray MD

01 May 2021

27 Apr 2021

Point of View of Cancer Rose about MyPEBS-study in BMJ

27 Apr 2021

Decision Support Tools
Medias – Press
Archives
MyPEBS
Contact us

Liens externes

Nos formations
FORMINDEP
HelloAsso

Légal

Mentions légales
Confidentialité
Crédits

Toute reproduction totale ou partielle interdite. Réalisation : TECHBOX

Gérer le consentement

Pour offrir les meilleures expériences, nous utilisons des technologies telles que les cookies pour stocker et/ou accéder aux informations des appareils. Le fait de consentir à ces technologies nous permettra de traiter des données telles que le comportement de navigation ou les ID uniques sur ce site. Le fait de ne pas consentir ou de retirer son consentement peut avoir un effet négatif sur certaines caractéristiques et fonctions.

Fonctionnel Fonctionnel Always active

L’accès ou le stockage technique est strictement nécessaire dans la finalité d’intérêt légitime de permettre l’utilisation d’un service spécifique explicitement demandé par l’abonné ou l’utilisateur, ou dans le seul but d’effectuer la transmission d’une communication sur un réseau de communications électroniques.

Préférences Préférences

L’accès ou le stockage technique est nécessaire dans la finalité d’intérêt légitime de stocker des préférences qui ne sont pas demandées par l’abonné ou l’internaute.

Statistiques Statistiques

Le stockage ou l’accès technique qui est utilisé exclusivement à des fins statistiques. Le stockage ou l’accès technique qui est utilisé exclusivement dans des finalités statistiques anonymes. En l’absence d’une assignation à comparaître, d’une conformité volontaire de la part de votre fournisseur d’accès à internet ou d’enregistrements supplémentaires provenant d’une tierce partie, les informations stockées ou extraites à cette seule fin ne peuvent généralement pas être utilisées pour vous identifier.

Marketing Marketing

L’accès ou le stockage technique est nécessaire pour créer des profils d’internautes afin d’envoyer des publicités, ou pour suivre l’utilisateur sur un site web ou sur plusieurs sites web ayant des finalités marketing similaires.

Manage options Manage services Manage {vendor_count} vendors Read more about these purposes

Voir les préférences

{title} {title} {title}

Scroll to Top